Use access key #2 to skip to page content.

TMFHelical (98.80)

Academic drugs



September 18, 2007 – Comments (0)

One item that gets a lot of press and inadvertently gives the public the impression that the drug industry is dragging its collective feet is academic PR.  I see a lot of biotech news services, and occasionally the general press, picking up on some recently published academic research where the latest CURE to x y or z has been discovered.  These are typically in model systems and generally don't go much further.

 So, to use this blog to link another, Derek Lowe has written a couple of recent commentaries on this subject. See:

Among other items (he's real good, and everyone in my industry should be reading him), he points out that the finds in academia seldom make for promising drug candidates for a variety of reasons.  How a compound will behave in the body and it promiscuity being the primary issues.  He gives an example of just such a compound in the second post. he also points out, these non-drug compounds can be wonderful research tools that go a long way to advancing our knowedge about targets, disease states, etc.  We are fortunate IMO that the government has always seen fit to fund a good deal of purely academic research.  While it may not show us the next great drug, it will almost certainly help light the way.


0 Comments – Post Your Own

Featured Broker Partners